Astrana Health (ASTH) 2024年10-K年度报告「NASDAQ」.pdf

1、 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-K(Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31,2024ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 19

2、34 for the transition period from _ to _.Commission file number:001-37392Astrana Health,Inc.(Exact name of registrant as specified in its charter)Delaware 95-4472349(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)1668 S.Garfield Avenue,2nd Floor,Alhambr

3、a,California 91801(Address of principal executive offices,including zip code)Registrants telephone number,including area code:(626)282-0288Securities registered pursuant to Section 12(b)of the Act:Title of Each Class Trading Symbol Name of Each Exchange on Which RegisteredCommon Stock,$0.001 par val

4、ue per share ASTH The Nasdaq Stock Market LLCSecurities registered pursuant to Section 12(g)of the Act:None(Title of class)Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No Indicate by check mark if the registrant is not requ

5、ired to file reports pursuant to Section 13 or Section 15(d)of the Exchange Act.Yes No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period tha

6、t the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(23